There are several forms of ALD. Onset of the classic childhood form, which is the most severe and affects only boys, may occur between ages 4 and 10. Features of this form may include visual loss, learning disabilities, seizures, dysphagia, deafness, disturbances of gait and coordination, fatigue, intermittent vomiting, and progressive dementia. The most common symptoms are usually behavioral changes such as abnormal withdrawal or aggression, poor memory, and poor school performance.
In the milder adult-onset form, which typically begins between ages 21 and 35, symptoms may include leg stiffness, progressive spastic paraparesis of the lower extremities, and ataxia. Although adult-onset ALD progresses more slowly than the classic childhood form, it can also result in deterioration of brain function.
Another form of ALD is occasionally seen in women who are carriers of the disorder. Symptoms are mild and may include spastic paraparesis of the lower limbs, ataxia, hypertonia, mild peripheral neuropathy, and urinary problems.
Neonatal ALD affects both male and female newborns. Neonatal adrenoleukodystrophy (NALD) is a disorder that is totally distinct from X-linked adrenoleukodystrophy. NALD was assigned that name when its nature was not yet understood, and this nomenclature has led to unfortunate confusion. NALD is now classified as a disorder of peroxisome biogenesis it is related to the Zellweger syndrome. NALD and X-linked adrenoleukodystrophy never occur in the same family. Symptoms may include intellectual disabilities, facial abnormalities, seizures, retinal degeneration, hypotonia, heptomegaly, and adrenal dysfunction. This form is usually quickly progressive.
Kennedy Krieger Genetics Laboratories
·Genetic, Metabolic and Degenerative Brain Disorders Research*
·Molecular Neuroscience Research
·Lena Bezman, M.D., M.P.H.
·Michael F. Cataldo, Ph.D.
·S. Ali Fatemi, MD
·Richard O. Jones, Ph.D.
·Ann B. Moser, B.A.
·SakkuBai Naidu, M.D.
·James J. Pekar, Ph.D.
·Gerald V. Raymond, M.D.
·Kirby D. Smith, Ph.D.
·Seth Smith, Ph.D.
·Steven Steinberg, Ph.D.
·Carol Tiffany
·Paul A. Watkins, M.D., Ph.D
·Peter C. M. van Zijl, Ph.D.
·Hugo Moser, Neurologist World-Renowned for his Relentless Fight Against Adrenoleukodystrophy (ALD), Dies at Age 82
·New Study Shows Use of Lorenzo's Oil Prevents Onset of Debilitating Pediatric Neurological Disorder
·Statement of Condolence for the Family of Lorenzo Odone
X-linked Adrenoleukodystrophy Database
(www.x-ald.nl)
The ALD Foundation
(www.aldfoundation.org)
Clinical Programs l School Programs l Research


